Latest Headlines

  1. CDMO AGC Biologics Announces Manufacturing Expansion Plans For Two Facilities

    AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that their development and manufacturing capabilities at their Seattle, Washington and Copenhagen, Denmark facilities will be expanded, as part of an ongoing commitment to deliver the highest standard of service for their customers.

  2. ATCC Announces $22M Facility Expansion In Virginia

    ATCC launched its second headquarters expansion with a new operations campus in Prince William County, Virginia.

  3. Experienced Technical Specialist Takes Up Market Development Manager Role At Parker Bioscience Filtration

    Parker Bioscience Filtration has appointed a new Market Development Manager-Biopharma to support its growth in the biopharmaceutical manufacturing sector.

  4. AES Announces Sales Manager Opening For Western US Region

    The Sales Manager has primary responsibility for AES business development activities within the Western Region.

  5. ISPE Announces CRB As 2019 Company Of The Year At Annual Meeting

    CRB was recognized as the 2019Company of the Yearby the International Society for Pharmaceutical Engineering (ISPE) during the organization's annual meeting inLas Vegas, Nevadaon Oct. 27–30, 2019.

  6. Meissner To Deliver A ‘Live Lab’ Demonstration At BioProduction Congress, Frankfurt, Germany

    Meissner will deliver a hands-on demonstration of their CryoVault™ Platform for bulk drug substance at BioProduction Congress. The event, which is now part of CPhI Worldwide in Frankfurt, Germany will take place at Messe Frankfurt on 5-7 November 2019.

  7. Prelude Therapeutics Announces Investment And Expansion Of Labs In Delaware

    Prelude Therapeutics, a privately-held, clinical-stage biopharmaceutical company, will invest $5M in expanded lab and office space in metro Wilmington, Delaware.

  8. New KUBio Box For Viral Vectors Boosts Gene Therapy Manufacturing

    GE Healthcare Life Sciences is launching KUBio™ box, a fully-integrated, flexible, and adaptable biomanufacturing environment to accelerate the production of viral vector-based gene therapies. The latest addition to the KUBio modular bioprocessing portfolio, KUBio box is expected to speed gene therapies to market and contribute to increased capacity in the viral vector area.

  9. Bio-Techne Announces Investment For New GMP Manufacturing Facility

    Bio-Techne Corporation (NASDAQ: TECH), a global leader in the development and manufacturing of Good Manufacturing Practices (GMP)-grade raw and ancillary reagents, announced a commitment to invest between $40 million and $50 million to expand its GMP-grade protein production capacity.

  10. United Therapeutics Receives Permit For Cell Therapy Facility Build-Out At Mayo

    United Therapeutics received a building permit Tuesday for a $9.5M build-out of its cell therapy facility on the second floor of Mayo Clinic’s Discovery and Innovation Building.